Overall Exam Verdict

The May/June 2026 series for Cambridge International AS & A Level Biology (9700) maintains a standard yet rigorous level of difficulty (rated 3.4 / 5.0). Across the component papers—ranging from multiple choice (Paper 11) and theory (Papers 21 & 41) to practical investigation and planning (Papers 31 & 51)—the assessment demands strong conceptual clarity, rigorous scientific vocabulary, and disciplined quantitative skills.

Where the Marks Were Won and Lost

Substantial mark allocations were concentrated in core biochemical pathways and biological mechanisms:

  • Cell Structure and Molecular Genetics: High-scoring candidates clearly distinguished between purines and pyrimidines, outlined eukaryotic protein secretion pathways via the RER and Golgi apparatus, and detailed the enzymatic roles of DNA polymerase and ligase during replication.
  • Physiological Transport & Regulation: Marks were reliably scored on phloem sucrose loading via \(\text{H}^+\) symport (SWEET proteins) and stomatal control by abscisic acid (\(\text{ABA}\)). However, candidates lost marks by confusing receptor cells with receptor proteins or misstating the direction of ion fluxes across guard cell membranes.
  • Evolution and Genetics: The dihybrid cross and linkage analysis proved discriminating; many failed to explicitly link equal parental gamete expectations to independent assortment in metaphase I versus autosomal gene linkage.
  • Practical Design and Analysis (Papers 31 & 51): Candidates secured full marks on proportional dilutions and drawing conventions, but struggled with precise sources of experimental error, respirometer calculations involving cross-sectional area (\(\pi r^2\)), and articulating conditions for statistical tests like the student's \(t\)-test.

Examiner Pitfalls & Strategy for High Scores

A prevalent pitfall was the imprecise use of terminology—such as stating cells 'replicate' rather than 'divide by mitosis', or confusing 'stoma' with 'guard cell'. In genetic engineering, detailing the specific vectors and steps for ADA gene therapy required complete sequence steps rather than vague summaries. Future candidates must focus on structured, sequential prose for multi-mark 'Describe' and 'Explain' prompts, explicitly stating intermediate mechanisms (e.g., active transport establishing concentration gradients followed by facilitated diffusion).